Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful helicobacter pylori eradication - a 7-year follow-up study

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 4, 2009, Pages 297-303

  Maconi, Giovanni ^a   Sainaghi, Massimo ^a   Molteni, Mirko ^a   Bosani, Matteo ^a   Gallus, Silvano ^b   Ricci, Giorgio ^c   Alvisi, Vittorio ^c   Porro, Gabriele Bianchi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Dyspepsia; Eradication; Helicobacter pylori; Predictors; Sduodenal ulcer

Indexed keywords

AMOXICILLIN; ANTACID AGENT; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DUODENUM ULCER; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE NEED; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REMISSION; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; DYSPEPSIA; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS; TREATMENT OUTCOME;

EID: 67649624658     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283069db0     Document Type: Article

References (26)

1. Jones RH. Clinical economics review: gastrointestinal disease in primary care. Aliment Pharmacol Ther 1996; 10:233-239.
2. Labenz J. Consequences of Helicobacter pylori cure in ulcer patients. Baillieres Best Pract Res Clin Gastroenterol 2000; 14:133-145.
3. Reilly TG, Ayres RCS, Poxon V, Walt RP. Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther 1995; 9:483-490.
4. Van der Wouden EJ, Thijs JC, van Zwet AA, Kleibeuker JH. Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2001; 13:1235-1239.
5. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005; 1:CD002096.
6. Bazzoli F, Bianchi Porro G, Maconi G, Molteni M, Pozzato P, Zagari RM. Present indications and therapeutic modalities of Helicobacter pylori eradication. Digest Liver Dis 2002; 34:70-83.
7. Heikkinen M, Farkkila M. What is the long-term outcome of the different subgroups of functional dyspepsia? Aliment Pharmacol Ther 2003; 18:223-229.
8. Heikkinen M, Farkkila M. Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infectio. A 6-7-year follow-up study. Scand J Gastroenterol 2002; 37:905-910.
9. Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7:829-833.
10. McNamara D, Buckley M, Gilvarry J, O’Morain C. Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study. Helicobacter 2002; 7:317-321.
11. Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G. Do some patients with H.pylori infection benefit from an extension to two weeks of a PPI-based triple eradication therapy? Am J Gastroenterol 2001; 96:359-366.
12. Stanghellini V, Anti M, Bianchi Porro G, Corinaldesi R, Gasbarrini G, Giacosa A, et al. Risk indicators of organic diseases in uninvestigated dyspepsia: a one-week survey in 246 Italian endoscopy units. Eur J Gastroenterol Hepatol 1999; 11:1129-1134.
13. Bytzer P, Aalykke C, Rune S, Weywadt L, Gjørup T, Eriksen J, et al. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer diseas. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol 2000; 35:1023-1032.
14. Seo M, Okada M, Shirotani T, Nishimura H, Maeda K, Aoyagi K, Sakisaka S. Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. J Clin Gastroenterol 2002; 34:129-134.
15. Pace F, Bianchi Porro G. Gastro-oesophageal reflux and Helicobacter pylori. Ital J Gastroenterol Hepatol 1998; 30 (Suppl 3):S289-S293.
16. Martino G, Paoletti M, Marcheggiano A, D’Ambra G, Delle Fave G, Annibale B. Duodenal ulcer relapse is not always associated with recurrence of H.pylori infection: a prospective three-year follow-up study. Helicobacter 1999; 4:213-217.
17. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroduodenal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96:2905-2914.
18. Sloth H, Jorgensen LS. Chronic non-organic upper abdominal pain, diagnostic safety and prognosis of gastrointestinal and non-intestinal symptom. A 5-7-year follow-up study. Scand J Gastroenterol 1988; 23:1275-1280.
19. Barnes RJ, Uff JS, Dent JC, Gear MW, Wilkinson SP. Long-term follow-up of patients with gastritis associated with Helicobacter pylori infection. Br J General Pract 1991; 41:286-288.
20. Meineche-Schmidt V, Jorgensen T. Investigation and therapy in patients with different types of dyspepsia: a 3 year follow-up study from general practice. Fam Pract 2000; 17:514-521.
21. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 19:CD002096.
22. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, et al. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol 1999; 34:566-574.
23. Tan AC, Hartog GD, Mulder CJ. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication. Aliment Pharmacol Ther 1999; 13:1519-1522.
24. Khan Z, Nair P, O’Shea C, Spiers N, Playford RJ, Wicks AC. Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study. Scand J Gastroenterol 2002; 37:144-147.
25. Rollan A, Giancaspero R, Fuster F, Acevedo C, Figueroa C, Hola K, et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000; 95:50-56.
26. Abu-Mahfouz MZ, Prasad VM, Santoigade P, Cutler AF. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 1997; 92:2025-2028.